35950 Federal Register / Vol. 65, No. 109 / Tuesday, June 6, 2000 / Notices

660 and amended, HRSA is requesting

nominations for three voting members

of the ACCV.

The ACCV advises the Secretary on

the implementation of the VICP; on its

own initiative or as the result of the

filing of a petition, recommends changes

in the Vaccine Injury Table; advises the

Secretary in implementing the

Secretary’s responsibilities under

section 2127 regarding the need for

childhood vaccination products that

result in fewer or no significant adverse

reactions; surveys Federal, State, and

local programs and activities relating to

the gathering of information on injuries

associated with the administration of

childhood vaccines, including the

adverse reaction reporting requirements

of section 2125(b); advises the Secretary

on means to obtain, compile, publish,

and use credible data related to the

frequency and severity of adverse

reactions associated with childhood

vaccines; and recommends to the

Director, National Vaccine Program

Office, research related to vaccine

injuries which should be conducted to

carry out the VICP.

The ACCV consists of nine voting

members appointed by the Secretary as

follows: three health professionals, of

whom at least two are pediatricians,

who are not employees of the United

States, who have expertise in the health

care of children, the epidemiology,

etiology and prevention of childhood

diseases, and the adverse reactions

associated with vaccines; three members

from the general public, of whom at

least two are legal representatives

(parents or guardians) of children who

have suffered a vaccine-related injury or

death; and three attorneys, of whom at

least one shall be an attorney whose

specialty includes representation of

persons who have suffered a vaccinerelated injury or death, and one shall be

an attorney whose specialty includes

representation of vaccine

manufacturers. In addition, the Director

of the National Institutes of Health, the

Assistant Secretary for Health, the

Director of the Centers for Disease

Control and Prevention, and the

Commissioner of the Food and Drug

Administration (or the designees of such

officials) serve as nonvoting ex officio

members.

Specifically, HRSA is requesting

nominations for three voting members

of the ACCV representing: (1) a health

professional with special experience in

childhood diseases; (2) an attorney

whose specialty includes representation

of a vaccine manufacturer and (3) a

member from the general public.

Nominees will be invited to serve 3-year

terms beginning January 1, 2001, and

ending December 31, 2003.

Interested persons may nominate one

or more qualified persons for

membership on the ACCV. Nominations

shall state that the nominee is willing to

serve as a member of the ACCV and

appears to have no conflict of interest

that would preclude the ACCV

membership. Potential candidates will

be asked to provide detailed information

concerning such matters as financial

holdings, consultancies, and research

grants or contracts to permit evaluation

of possible sources of conflicts of

interest. A curriculum vitae or resume

should be submitted with the

nomination.

The Department of Health and Human

Services has special interest in assuring

that women, minority groups, and the

physically handicapped are adequately

represented on advisory committees and

therefore extends particular

encouragement to nominations for

appropriately qualified female,

minority, or physically handicapped

candidates.

Dated: May 30, 2000.

Claude Earl Fox,

Administrator, HRSA.

[FR Doc. 00–14041 Filed 6–5–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Advisory Commission on Childhood

Vaccines (ACCV); Notice of Meeting;

Cancellation

Federal Register Document 00–11251,

in the issue dated Friday, May 5, 2000,

on the following pages 26219–26220,

the Advisory Commission on Childhood

Vaccines meeting scheduled for June 7,

2000, has been cancelled due to lack of

quorum.

Dated: May 31, 2000.

Jane M. Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–14107 Filed 6–5–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service

Availability of Draft Comprehensive

Conservation Plan and Environmental

Assessment for Tewaukon National

Wildlife Refuge Complex, Cayuga, ND.

AGENCY: Fish and Wildlife Service,

Interior.

ACTION: Notice of availability.

SUMMARY: Pursuant to the Refuge

Improvement Act of 1997, the U.S. Fish

and Wildlife Service has published the

Tewaukon National Wildlife Refuge

Complex Draft Comprehensive

Conservation Plan and Environmental

Assessment. This Plan describes how

the FWS intends to manage the

Tewaukon NWR and Wetland

Management District for the next 10–15

years.

DATES: Submit written comments by

July 6, 2000. All comments need to be

addressed to Allison Banks, Refuge

Planner, Land Acquisition and Refuge

Planning, U.S. Fish and Wildlife

Service, P.O. Box 25486 DFC, Denver,

Colorado 80225.

ADDRESSES: A copy of the Plan may be

obtained by writing to U.S. Fish and

Wildlife Service, 9754 1431⁄2 Avenue

SE, Cayuga, ND 58013–9764; or

download from http://www.r6.fws.gov/

larp/.

FOR FURTHER INFORMATION CONTACT:

Allison Banks, U.S. fish and Wildlife

Service, P.O. Box 25486 DFC, Denver,

CO 80225, 303/236–8145 extension 626;

fax 303/236–4792.

SUPPLEMENTARY INFORMATION: Tewaukon

NWR Complex is located in southeast

North Dakota. Implementation of the

Plan will focus on adaptive resource

management of glaciated prairie

wetlands, tall and mixed grass prairie

grasslands, riparian woodlands, and

opportunities for compatible wildlifedependent recreation. Habitat

monitoring and evaluation will be

emphasized as the Plan is implemented.

Opportunities for compatible wildlifedependent recreation will continue to

be provided.

Dated: May 31, 2000.

Ralph O. Morgenweck,

Regional Director, Denver, Colorado.

[FR Doc. 00–14100 Filed 6–5–00; 8:45 am]

BILLING CODE 4310–55–M